Clinical Trials Browser

Oligodendroglioma × Therapeutics × CNS × Clear all

NCT00360828 2017-03-23

Phase II Study of Irinotecan HCI for Recurrent Anaplastic Astrocytomas, Mixed Malignant Gliomas, and Oligodendrogliomas

Phase 2 Terminated

10 enrolled 6 charts

Astrocytoma, Brain Neoplasms, Glioma, Neurologic Manifestations, Oligodendroglioma